CHE
Chemed Corporation
Set alert
534.72 USD -7.20 -1.33%
533.25 Day range 550.93
368.59 52-week range 552.72
- YTD
- +24.98%
- 1 year
- +17.67%
- Open
- 545.01
- Prev close
- 541.92
- Mkt cap
- 6.93B
- Vol
- 180.47K
- Avg vol
- 154.34K
- EPS
- 20.88
- P/E
- 25.61
- Div yield
- 0.52%
More statistics
- Low
- 533.25
- High
- 550.93
- Forward P/E
- 19.45
- Beta
- 0.51
- Short ratio
- 4.25
- Inst. own
- 105.43%
- Dividend
- 2.80
- Ex-div date
- Aug 16, 2026
- Earnings
- Feb 24, 2027
- 50-d avg
- 514.74
- 200-d avg
- 462.35
- 1y target
- 617.00
Key statistics
- Market cap
- 7.02B
- Enterprise value
- 7.42B
- Trailing P/E
- 25.95
- Forward P/E
- 19.45
- PEG ratio
- 1.98
- Price / sales
- 2.64
- Price / book
- 8.21
- EPS (TTM)
- 20.88
- Beta
- 0.51
- Dividend yield
- 0.52%
- Payout ratio
- 12.07%
- Profit margin
- 10.61%
- Revenue (TTM)
- 2.66B
- Revenue growth
- 10.60%
- Free cash flow
- 262.60M
- Total cash
- 48.43M
- Total debt
- 392.19M
- Return on equity
- 29.14%
- Shares outstanding
- 12.96M
- Short % of float
- 6.24%
- 50-day average
- 514.74
- 200-day average
- 462.35
Analyst view
Consensus: buy
Buy
Price target (mean) 617.00 +15.4% upside
Now 534.72
- Target (low)
- 580.00
- Target (mean)
- 617.00
- Target (high)
- 675.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 7.35.
Financials — quick view
CHE Revenue — quarterly 673.25M
CHE Net income — quarterly 67.70M
CHE EPS — quarterly 5.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 7.35 | — | — | — |
| Oct 27, 2026 | Sep 30, 2026 | 6.44 | 6.75 | +0.31 | +4.81% |
| Jul 28, 2026 | Jun 30, 2026 | 5.60 | 6.06 | +0.46 | +8.21% |
| Apr 23, 2026 | Mar 31, 2026 | 5.30 | 5.65 | +0.35 | +6.60% |
| Feb 25, 2026 | Dec 31, 2025 | 7.02 | 6.42 | -0.60 | -8.55% |
| Oct 28, 2025 | Sep 30, 2025 | 5.39 | 5.27 | -0.12 | -2.23% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Oct 29, 2026 | UBS | main | Buy | Buy |
| Oct 29, 2026 | Oppenheimer | main | Outperform | Outperform |
| Oct 28, 2026 | Jefferies | up | Hold | Buy |
| Sep 25, 2026 | UBS | init | — | Buy |
| Jul 31, 2026 | Oppenheimer | main | Outperform | Outperform |
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- chemed.com
News
- RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $585
- Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $625
- What Chemed (CHE) Said on Its Q3 Earnings Call
- Jefferies Upgrades Chemed to Buy, Raises Price Target to $620
- Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript
- Chemed Q3 2026 Earnings Call Transcript
- Here Are Wednesday’s Top Wall Street Analyst Research Calls: Enphase Energy, F5, Marvell Technology, MSG Rangers, Pentair, Silicon Motion Technology, Spotify Technology, Texas Instruments, Whirlpool, and More
- Chemed (CHE) Tops Q3 Earnings and Revenue Estimates
- Chemed Reports Third-Quarter 2026 Results
Your note
Sign in to keep a note on CHE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DELYONS RON | Director | Stock Award(Grant) | May 17, 2026 | 2,052 |
| GRACE PATRICK P | Director | Sale | Jul 30, 2026 | 3,533 |
| HEANEY CHRISTOPHER J | Director | Stock Award(Grant) | May 17, 2026 | 2,775 |
| HUTTON THOMAS CHARLES | Officer and Director | Conversion of Exercise of derivative security | Sep 27, 2026 | 32,840 |
| JUDKINS BRIAN C | Officer | Conversion of Exercise of derivative security | Aug 9, 2026 | 3,344 |
| LEE SPENCER S | Officer | Conversion of Exercise of derivative security | Sep 29, 2026 | 14,851 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.36% | 1,484,282 | 804.12M | Jun 29, 2026 |
| AQR Capital Management, LLC | 7.44% | 972,474 | 526.85M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.02% | 787,068 | 426.40M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.62% | 604,420 | 327.45M | Jun 29, 2026 |
| Acadian Asset Management. LLC | 3.47% | 453,238 | 245.55M | Jun 29, 2026 |
| State Street Corporation | 3.40% | 444,716 | 240.93M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 465,608 | 252.25M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.26% | 426,035 | 230.81M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.35% | 307,739 | 166.72M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.93% | 251,878 | 136.46M | Aug 30, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 1.61% | 210,584 | 114.09M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.35% | 176,971 | 95.88M | Jun 29, 2026 |